By binding to YBX1, tRF-2s effectively sequester this protein, preventing it from stabilizing cancer-promoting transcripts and thereby inhibiting tumor progression (Goodarzi et al., 2015; Kumar et al., 2016). The gene discussed is YBX1; the disease is neoplasm.